Review of Factors Affecting Remission in Narcological Patients
Journal: I.P. Pavlov Russian Medical Biological Herald (Vol.31, No. 1)Publication Date: 2023-03-31
Authors : T. V. Agibalova; V. N. Nobatova; O. D. Tuchina; E. V. Leonov; A. P. Pinegin; E. I. Tukhvatullina;
Page : 155-163
Keywords : narcological diseases; sustained remission; failure; relapse; factors;
Abstract
INTRODUCTION: Achievement of a sustained remission in patients with substance dependence syndrome is the main criterion of the quality of narcological treatment and a priority treatment task. The article presents a review of factors that influence remission in patients with mental and behavioral disorders resulting from use of psychoactive substances. Studies performed in the recent 15 years, consider the main five groups of factors for development and failure of remission: biological (gender, age, genetic parameters, organic lesions of the brain, etc.), narcological (course of the disease, age at the first use of a drug), personality and pathopsychological (cognitive disorders, comorbid mental disorders, mental trauma, etc.), social (employment, family and social situation, social support, etc.) and therapeutic factors (duration and methods of treatment, therapeutic alliance, etc.).
CONCLUSION: There are basic factors of favorable prognosis of the course of narcological diseases that are confirmed from study to study: late onset of the disease, absence of a comorbid dependence syndrome and of a severe mental disorder, involvement in long-term treatment and rehabilitation programs that continue after remission.
Other Latest Articles
- Suture Failure of Duodenum after Surgery for Complications of Duodenal Ulcer
- Role of Myocardial Bridging in Myocardial Ischemia: Clinical Case Report
- Two Rare Anatomical Variants of Femoral Triangle Vessels in One Patient: Case Report
- Systemic Inflammatory Response Syndrome and Serum Procalcitonin in Odontogenic Maxillofacial Infection
- Evaluation of Overall Survival Rate of Patients with Metastatic Colorectal Cancer Depending on Choice of Treatment, Location of Primary Focus and RAS Genes Mutation Status
Last modified: 2023-04-03 23:55:16